 |
인쇄하기
취소
|
Unreasonable Collective Implementation of bio-equivalent Test
The pharmaceutical industry issued a strong opinion that enforcing the bio-equivalent test only for the sake of substitutable dispensation without any consideration of economic factors should be stopped.
The KFDA has been receiving the requisition for the bio-equivalent test and as of August 6 the number of items is about 570.
However, in the case of applied items some of them are not ...
The KFDA has been receiving the requisition for the bio-equivalent test and as of August 6 the number of items is about 570.
However, in the case of applied items some of them are not ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.